ArticleBlood advances2023

Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up.

Alexander Röth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.